Literature DB >> 26497477

The Microbiome in Mental Health: Potential Contribution of Gut Microbiota in Disease and Pharmacotherapy Management.

Stephanie A Flowers1, Vicki L Ellingrod1,2.   

Abstract

The gut microbiome is composed of ~10(13) -10(14) microbial cells and viruses that exist in a symbiotic bidirectional communicative relationship with the host. Bacterial functions in the gut have an important role in healthy host metabolic function, and dysbiosis can contribute to the pathology of many medical conditions. Alterations in the relationship between gut microbiota and host have gained some attention in mental health because new evidence supports the association of gut bacteria to cognitive and emotional processes. Of interest, illnesses such as major depressive disorder are disproportionately prevalent in patients with gastrointestinal illnesses such as inflammatory bowel disease, which pathologically has been strongly linked to microbiome function. Not only is the microbiome associated with the disease itself, but it may also influence the effectiveness or adverse effects associated with pharmacologic agents used to treat these disorders. This field of study may also provide new insights on how dietary agents may help manage mental illness both directly as well as though their influence on the therapeutic and adverse effects of psychotropic agents.
© 2015 Pharmacotherapy Publications, Inc.

Entities:  

Keywords:  drug metabolism; metagenomics; microbiome; psychiatry

Mesh:

Substances:

Year:  2015        PMID: 26497477     DOI: 10.1002/phar.1640

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  8 in total

1.  Effects of Atypical Antipsychotic Treatment and Resistant Starch Supplementation on Gut Microbiome Composition in a Cohort of Patients with Bipolar Disorder or Schizophrenia.

Authors:  Stephanie A Flowers; Nielson T Baxter; Kristen M Ward; A Zarina Kraal; Melvin G McInnis; Thomas M Schmidt; Vicki L Ellingrod
Journal:  Pharmacotherapy       Date:  2019-02-03       Impact factor: 4.705

Review 2.  Harnessing Gut Microbes for Mental Health: Getting From Here to There.

Authors:  Annadora J Bruce-Keller; J Michael Salbaum; Hans-Rudolf Berthoud
Journal:  Biol Psychiatry       Date:  2017-08-30       Impact factor: 13.382

3.  Deletion of ghrelin alters tryptophan metabolism and exacerbates experimental ulcerative colitis in aged mice.

Authors:  Ellie Tuchaai; Valerie Endres; Brock Jones; Smriti Shankar; Cory Klemashevich; Yuxiang Sun; Chia-Shan Wu
Journal:  Exp Biol Med (Maywood)       Date:  2022-07-14

Review 4.  Cytotoxicity of Nanoparticles Contained in Food on Intestinal Cells and the Gut Microbiota.

Authors:  Esther E Fröhlich; Eleonore Fröhlich
Journal:  Int J Mol Sci       Date:  2016-04-06       Impact factor: 5.923

5.  Gut Microbiome Composition in Non-human Primates Consuming a Western or Mediterranean Diet.

Authors:  Ravinder Nagpal; Carol A Shively; Susan A Appt; Thomas C Register; Kristofer T Michalson; Mara Z Vitolins; Hariom Yadav
Journal:  Front Nutr       Date:  2018-04-25

Review 6.  A Review of Traumatic Brain Injury and the Gut Microbiome: Insights into Novel Mechanisms of Secondary Brain Injury and Promising Targets for Neuroprotection.

Authors:  Caroline S Zhu; Ramesh Grandhi; Thomas Tyler Patterson; Susannah E Nicholson
Journal:  Brain Sci       Date:  2018-06-19

7.  Bugs and Brains, the Gut and Mental Health Study: a mixed-methods study investigating microbiota composition and function in anxiety, depression and irritable bowel syndrome.

Authors:  Carra A Simpson; Orli S Schwartz; Djamila Eliby; Catherine A Butler; Katherine Huang; Neil O'Brien-Simpson; Bridget L Callaghan; Stuart G Dashper; Paul R Gooley; Sarah Whittle; Nick Haslam; Julian G Simmons
Journal:  BMJ Open       Date:  2021-03-15       Impact factor: 2.692

Review 8.  Gut Microbiota and Acute Central Nervous System Injury: A New Target for Therapeutic Intervention.

Authors:  Bin Yuan; Xiao-Jie Lu; Qi Wu
Journal:  Front Immunol       Date:  2021-12-24       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.